| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Nextage Therapeutics Ltd (TA: MCTC)
MCTC Technical Analysis
5
| As on 11th Jun 2023 MCTC STOCK Price closed @ 95.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 151.98 & Strong Sell for SHORT-TERM with Stoploss of 236.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MCTCSTOCK Price
| Open | 44.00 | Change | Price | % |
| High | 99.00 | 1 Day | 45.00 | 90.00 |
| Low | 44.00 | 1 Week | 62.50 | 192.31 |
| Close | 95.00 | 1 Month | 47.00 | 97.92 |
| Volume | 542232 | 1 Year | -181.10 | -65.59 |
| 52 Week High 282.00 | 52 Week Low 26.10 | ||||
TA Israel Most Active Stocks
| TA125 | 2008.05 | 1.06% |
| BEZQ | 472.70 | -0.06% |
| GLEX | 8.50 | 10.39% |
| CANF | 3.20 | -3.03% |
| GIVO-L | 47.30 | 0.00% |
| LUMI | 2815.00 | 1.26% |
| ELAL | 394.00 | 3.55% |
| GNRS | 78.90 | 1.41% |
| BLRX | 37.60 | -2.08% |
| TDGN-L | 171.50 | 17.55% |
TA Israel Top Gainers Stocks
TA Israel Top Losers Stocks
| MCTC Daily Charts |
MCTC Intraday Charts |
Whats New @ Bazaartrend |
MCTC Free Analysis |
|
|
MCTC Important Levels Intraday
| RESISTANCE | 200.99 |
| RESISTANCE | 167.00 |
| RESISTANCE | 145.99 |
| RESISTANCE | 124.98 |
| SUPPORT | 65.03 |
| SUPPORT | 44.02 |
| SUPPORT | 23.01 |
| SUPPORT | -10.99 |
MCTC Forecast April 2024
| 4th UP Forecast | 264.19 |
| 3rd UP Forecast | 209.93 |
| 2nd UP Forecast | 176.39 |
| 1st UP Forecast | 142.85 |
| 1st DOWN Forecast | 47.15 |
| 2nd DOWN Forecast | 13.61 |
| 3rd DOWN Forecast | -19.93 |
| 4th DOWN Forecast | -74.19 |
MCTC Weekly Forecast
| 4th UP Forecast | 176.13 |
| 3rd UP Forecast | 150.11 |
| 2nd UP Forecast | 134.03 |
| 1st UP Forecast | 117.94 |
| 1st DOWN Forecast | 72.06 |
| 2nd DOWN Forecast | 55.97 |
| 3rd DOWN Forecast | 39.89 |
| 4th DOWN Forecast | 13.87 |
MCTC Forecast2024
| 4th UP Forecast | 586 |
| 3rd UP Forecast | 428.53 |
| 2nd UP Forecast | 331.2 |
| 1st UP Forecast | 233.87 |
| 1st DOWN Forecast | -43.87 |
| 2nd DOWN Forecast | -141.2 |
| 3rd DOWN Forecast | -238.53 |
| 4th DOWN Forecast | -396 |
Nextage Therapeutics Ltd ( TA Israel Symbol : MCTC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MCTC Business Profile
Nextage Therapeutics Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. It offers CellDetect, a diagnostic platform for early cancer detection, including bladder cancer, cervical cancer, and prostate cancer. The company also provides BRONJ Test, a test for bisphosphonate-related osteonecrosis of the jaw. In addition, it offers gene expression, and biomarker and histochemical assays for early cancer detection and personalized medicine. Further, the company provides diagnostic solutions for multiple cancer diagnostic applications. The company was formerly known as Micromedic Technologies Ltd and changed its name to Nextage Therapeutics Ltd in August 2020. Nextage Therapeutics Ltd is based in Tel Aviv, Israel. Address: Building 7, Entrance 1, Tel Aviv, Israel, 6158101
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service